Nuclear medicine broadly can be classified into diagnostic and therapeutic nuclear medicine. In last decade PET CT has transformed the oncological management, and today it has become the backbone of cancer diagnosis, early detection and follow up. There has been an exponential growth of this modality in the country, with about 250 installations in last 7-8 years.
After many decades of its clinical utilization, SPECT which is used for myocardial perfusion imaging, DTPA, DMSA, Bone scan etc has further consolidated its position due to its increasing use in specific clinical conditions.
Nuclear medicine therapies were restricted to high and low dose I-131 therapies for thyroid cancers and hyperthyroidism till recently, however clinical acceptance and usefulness of Lu-177 SSRTs in neuroendocrine tumors and prostate cancers have changed the scenario.